SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

JPMorgan Maintains Axalta at Neutral, Raises Price Target to $34

JPMorgan raised its price target from $33 to $34 while maintaining its Neutral rating. Axalta closed at $34.07 on Oct. 30.

AXTA

Related stories